In the study of nonspecific preparation, the response time (RT) to an imperative stimulus is analyzed as a function of the foreperiod (FP), the interval between a warning stimulus and the imperative stimulus. When FP is varied within blocks of trials, a downward sloping FP-RT function is usually observed. The slope of this function depends on the distribution of FPs (the more negative the skewness, the steeper the slope) and on intertrial sequences of FP (the longer the FP on the preceding trial, the steeper the slope). Because these determinants are confounded, we examined whether FP-RT functions, observed under three different FP distributions (i.e., uniform, exponential, and peaked) can be predicted, one from the other, by reweighting sequential effects. It turned out that reweighting explained very little variance of the difference between the FP-RT functions, suggesting a dominant role of temporal orienting strategies.
Observers performed a preview search task in which, on some trials, they had to indicate the presence of a briefly presented probe-dot. Probes could be presented on locations corresponding to old or new elements and prior to or after the presentation of the new elements. After the presentation of the new elements, probes were generally detected faster on new than on old locations, indicating prioritized selection of new elements. Prior to the presentation of the new elements, probes were detected faster on new than on old locations only when old and new elements differed in color. These results suggest that prioritized selection of new elements is mediated not by visual marking but by onset capture. Additionally, observers may apply color-based inhibition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.